Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Fundamentals

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
SHARE INFORMATION
Market CapUS$ 268 594 045
Shares Outstanding25 483 306
Float25 475 336
Percent Float99,97%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 1 144 000
Latest Fiscal EPSUS$ -1,20
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions88
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months312 738
Institutional Holdings Percent23,9%
Institutional Sold Previous 3 Months65 226
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months-
Insider Holdings Percent2,2
Insider Sold Previous 3 Months-
Insider Shares Owned572 771
TRADING INFO
52 Week HighUS$ 15,12
52 Week LowUS$ 4,41
52 Week High ChangeUS$ 49,50
21 Day Moving AverageUS$ 11,3086
21 Day Extended Moving AverageUS$ 10,9037
50 Day Moving AverageUS$ 9,845
50 Day Extended Moving AverageUS$ 10,0488
200 Day Moving AverageUS$ 6,7765
200 Day Extended Moving AverageUS$ 7,727
10 Day Average Volume196 351
20 Day Average Volume376 189
30 Day Average Volume911 496
50 Day Average Volume596 597
Alpha0.014314
Beta0.4814
Standard Deviation0.255208
R20.010076
7 Day Price ChangeUS$ -0,53
7 Day Percent Change-4,79%
21 Day Price ChangeUS$ -1,12
21 Day Percent Change-9,61%
30 Day Price ChangeUS$ -1,64
30 Day Percent Change-13,46%
Month to Date Price ChangeUS$ -0,53
Month to Date Percent Change-4,79%
Quarter to Date Price ChangeUS$ 3,16
Quarter to Date Percent Change42,82%
180 Day Price ChangeUS$ 5,25
180 Day Percent Change99,24%
200 Day Price ChangeUS$ 4,49
200 Day Percent Change74,21%
Year to Date Price ChangeUS$ 4,53
Year to Date Percent Change75,37%

Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Key Ratios

PROFITABILITY
EBIT Margin-2 930,8%
EBITDA Margin-2 866,7%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 1 053 000
Revenue Per ShareUS$ 0,0413
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book3,70
Total Debt To Equity0,00
Int Coverage0,00
Current Ratio13,60
Leverage Ratio1,40
Quick Ratio13,40
Long Term Debt To Capital0,03
VALUATION MEASURES
PE Ratio-7,90
Enterprise ValueUS$ 152 754 385
Price to Sales255,0751
Price to Free Cash23,80
PE High Last 5 Years-2,10
Price To Book3,70
Price To Cash Flow21,10
PE Low Last 5 Years-2,70
Price to Tangible Book3,70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-32,25
Return on Equity-43,63
Return on Capital-39,93

Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMarcum LLP
CEOSandesh Seth
Emplyoees32
Last AuditUQ
CIK0001388320
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address275 Madison Avenue
7th Floor
New York, NY 10016
Websitehttps://www.actiniumpharma.com
Facsimile+1 845 818-3588
Telephone+1 646 677-3870
Emailinvestorrelations@actiniumpharma.com
Dernières Valeurs Consultées
AMEX
ATNM
Actinium P..
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant
Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V:fr D:20221209 09:23:25